Skip to main content
Sastasundar Ventures Limited logo

Sastasundar Ventures Limited — Investor Relations & Filings

Ticker · SASTASUNDR ISIN · INE019J01013 BSE.NS Wholesale and retail trade
Open in API
Filings indexed 2 across all filing types
Latest filing 2026-05-22 Regulatory Filings
Country IN India
Listing BSE.NS SASTASUNDR

About Sastasundar Ventures Limited

https://sastasundarventures.com

Sastasundar Ventures Limited operates a digital healthcare platform focused on the distribution of pharmaceutical, wellness, and consumer goods. The company utilizes an integrated model that combines an online marketplace with a network of physical service points to facilitate the delivery of prescription medicines, over-the-counter products, and diagnostic services. Its core operations leverage technology and supply chain management to optimize the procurement and distribution of healthcare items. The platform provides health information and personalized services through a data-driven approach, aiming to improve accessibility and affordability for consumers. Key activities include managing a comprehensive inventory of healthcare products, coordinating last-mile logistics, and offering digital tools for health management.

Recent filings

Filing Released Lang Actions
Health X Platform Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Audited Standalone and ....
Regulatory Filings Classification · 85% confidence The document is a notice under SEBI Listing Obligations (Regulation 29) informing stock exchanges of an upcoming Board Meeting date to consider and approve audited financial results. It does not contain actual financial statements, nor is it a change in management, proxy material, dividend notice, or an AGM presentation. It is a routine regulatory announcement required by the exchange listing rules, which does not fit a more specific category. Therefore, it falls under the fallback category for miscellaneous regulatory filings (RNS).
2026-05-22 English
Intimation under Reg 30 of SEBI (LODR) Reg 2015 regarding completion of transfer of the entire equity stake of Mitsubishi Corporation held in Sastasundar Healthbuddy Limited, material subsidiary ....
Regulatory Filings Classification · 85% confidence The document is a stock exchange regulatory disclosure under SEBI LODR Regulation 30 regarding the completion of sale of equity stake in a material subsidiary. It notifies the exchanges of a corporate event but does not contain financial statements, voting results, dividend details, or an actual report. It’s a general compliance announcement. The most appropriate category is Regulatory Filings (RNS).
2026-05-15 English

Browse filings by year

1 year

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.